Biotech · Private company
Elekta Limited
Track this companyFree. Adds Elekta Limited to your Dealase workspace and tells you when its record changes.
Clinical trials85 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials8
- Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central LungEARLY_PHASE1 · RECRUITING · started Sep 19, 2025ClinicalTrials.gov NCT06712745 · fetched Nov 12, 2026
- A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal CancerPHASE2 · RECRUITING · started Nov 8, 2023ClinicalTrials.gov NCT06130280 · fetched Nov 12, 2026
- Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical CancerPHASE2 · COMPLETED · started Feb 1, 2022ClinicalTrials.gov NCT05021237 · fetched Nov 12, 2026
- A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain MetastasesNA · ACTIVE_NOT_RECRUITING · started Dec 14, 2021ClinicalTrials.gov NCT05341739 · fetched Nov 12, 2026
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRECRUITING · started Feb 1, 2019ClinicalTrials.gov NCT04075305 · fetched Nov 12, 2026
- A Prospective Study of Performing MRI Simulation in Treatment Position in Spinal Stereotactic Body Radiation TherapyACTIVE_NOT_RECRUITING · started Apr 21, 2018ClinicalTrials.gov NCT05155423 · fetched Nov 12, 2026
- Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After SurgeryPHASE2 · COMPLETED · started Jul 15, 2015ClinicalTrials.gov NCT02526498 · fetched Nov 12, 2026
- Chemoradiation or Brachytherapy for Rectal CancerPHASE2 · COMPLETED · started Jun 12, 2014ClinicalTrials.gov NCT02017704 · fetched Nov 12, 2026